Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.31% slid 0.01% to $170.18 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.20% falling 0.42% to 4,122.47 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.14% falling 0.18% to 32,774.41. This was the stock's fourth consecutive day of losses. Johnson & Johnson closed $16.51 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -4.18% rose 0.65% to $332.13, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK 0.00% rose 1.16% to $89.52, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.76% rose 0.42% to $49.78. Trading volume (5.5 M) remained 1.2 million below its 50-day average volume of 6.7 M.